Luminal breast cancer cells usually do not exhibit amplification of the EGF-signaling HER2 receptor or show only low over-expression of this receptor; nevertheless, they bind EGF and respond to its tumor-promoting stimuli [34–37]. This evidence concerns the gene EGF and neoplasm.